Breast cancer therapies' side effects vary by age
474153
NEW YORK  - Even among relatively young women with early-stage breast cancer, the side effects of therapy can vary by age, according to a new study.
725892
NEW YORK  - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.
459369
Hormone replacement therapy can raise the risk of an uncommon type of breast cancer fourfold after just three years, U.S. researchers reported on Monday.
575542
NEW YORK  - Breast cancer screening in the  US is common among women 80 years of age or older, but it is of  little benefit to the majority of them, according to a new  study.
371602
Many women are confused about what are the danger signs of breast cancer, a survey suggests.
447820
FRIDAY, Oct. 15 (HealthDayNews) -- Concerns about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients, according to a study published in the Oct. 15 issue of the Journal of Clinical Oncology.
359052
Elderly women with invasive cervical carcinoma are less likely to receive aggressive treatment than younger patients, and are more likely to die from the disease, a new study shows.
173266
NEW YORK  - Breast cancer patients who take  a multivitamin or extra vitamin E experience a smaller decrease  in important immune cells, a common side effect of  chemotherapy, new research suggests.
420095
Hormone replacement therapy can  raise the risk of an uncommon type of breast cancer fourfold  after just three years, U.S. researchers reported on Monday.
340360
Many young women diagnosed with breast cancer overestimate their risk of becoming infertile while undergoing treatment, a new study shows.
210480
NEW YORK  - Many young women diagnosed with  breast cancer overestimate their risk of becoming infertile  while undergoing treatment, a new study shows.
887
A new type of breast cancer drug is superior to the old standard, tamoxifen, in older women and should now be the first drug used to treat
13553
Post-menopausal women diagnosed with early-stage hormone-receptor (HR) positive breast cancer might be better off taking the drug anastrozole (Arimidex - brand name
117181
Even after more than a decade after diagnosis, cancer survivors may have a poorer quality of life and more health limitations than others their age, according to a US study.
567131
NEW YORK  - Many women who've had breast  cancer or are at high risk for the disease take tamoxifen for  years. A new study now shows that long-term tamoxifen use seems  to increase the risk of stroke, although the absolute increase  in risk is small.
562146
In women who&#39;ve been treated for breast cancer, use of the drug tamoxifen can help prevent recurrence of the disease. Now, new research indicates that the
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.